Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation
Lunna Li, Lianna D. Soriano, Welela M. Kedir, Felix L. Hoch, Desmond K. Loke · 2026
Read Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation by Lunna Li, Lianna D. Soriano, Welela M. Kedir, Felix L. Hoch, Desmond K. Loke (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538344.txt.
Description
Lunna Li and co-authors review, in twenty twenty-six, how AI and supercomputing are changing the search for new drugs. Computer-aided work in this field has grown fast. Structural data has piled up, and chemical libraries have grown huge. They now hold billions of drug-like molecules. To use them takes rapid virtual screening, which tests them in silico against a target. Deep learning improves guesses of target function and ligand traits. It helps even when full receptor structures are missing. The review covers the growth of chemical space and advanced screening methods.
It also covers molecular dynamics simulations, which model how molecules move. It covers ADMET work, which predicts absorption, distribution, metabolism, excretion, and toxicity. Lab checks close the loop by testing the computer results. The authors discuss the field's hard problems as compute power and data scale up.
Catalog record
| CREATOR | Lunna Li, Lianna D. Soriano, Welela M. Kedir, Felix L. Hoch, Desmond K. Loke |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 110 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |